Vegan Omega-3 (Algal EPA + DHA)
"Vegan omega-3" in this entry refers to long-chain omega-3 fatty acids — eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) — extracted from cultivated marine microalgae rather than from oily fish. Algal DHA / EPA carry the same UK-authorised health claims as fish-derived DHA / EPA at equivalent intakes. Plant oils such as flaxseed, chia, and walnut provide a different omega-3 — alpha-linolenic acid (ALA) — which converts to EPA / DHA in the body very inefficiently and is not the same supplement category.
Camden Medicals editorial · Last reviewed 1 May 2026 · Next review November 2026
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Fatty acid
- Typical daily dose
- Adequate intake for general adults: ~250 mg/day combined EPA + DHA. Pregnancy / breastfeeding: + 200 mg/day DHA on top of the 250 mg/day. Triglyceride maintenance claim: 2 g/day combined. Blood-pressure maintenance claim: 3 g/day combined. Doses above 3 g/day are typically a prescribing-supervision setting.
- Top use evidence
- Strong
On this page
What it is
EPA (eicosapentaenoic acid, 20:5 ω-3) and DHA (docosahexaenoic acid, 22:6 ω-3) are long-chain polyunsaturated fatty acids. In nature, they are synthesised primarily by marine microalgae; the fish that are commonly associated with omega-3 supplementation accumulate EPA and DHA by eating those microalgae (or by eating other organisms that ate them). Cultivated Schizochytrium sp. and Crypthecodinium cohnii microalgae, grown in fermenters, are the commercial vegan sources of DHA and EPA used in food supplementation in the UK and EU.
Algal oils are commonly supplied as soft-gels (with a vegetarian capsule shell — usually starch / carrageenan / modified cellulose rather than gelatin) or as liquid drops. Concentration of EPA and DHA per gram of oil varies by strain and processing — Schizochytrium typically delivers a DHA-dominant oil (high DHA, modest EPA), while Crypthecodinium delivers DHA only.
A separate category — flaxseed, chia, hemp, walnut and rapeseed oils — provides alpha-linolenic acid (ALA, 18:3 ω-3). The body converts a small fraction of ALA into EPA and very little into DHA; published estimates of the ALA-to-DHA conversion rate in adults sit in single-digit percentages or lower. ALA is a useful nutrient in its own right and has its own UK-authorised claims (it contributes to maintenance of normal blood cholesterol levels, at 2 g/day intake), but it is not a substitute for an algal EPA + DHA supplement if EPA / DHA is the goal.
At a glance
- Algal oil is the vegan source of long-chain omega-3 (EPA and DHA) — the same forms found in fish oil, just upstream in the food chain.
- EPA and DHA carry several UK-authorised health claims (heart, brain, vision, blood pressure, blood triglycerides) at specific intakes — see the regulatory section below.
- ALA from flax / chia / walnut is a different category — most of it does NOT convert to EPA / DHA. ALA is not a substitute for algal DHA / EPA.
- Algal oil is sustainable, lower in heavy-metal contamination risk than fish oil, and suitable for vegans, vegetarians, and people who do not eat fish.
- A standard 250 mg/day combined EPA+DHA dose meets the EFSA / NHS adequacy reference. Higher doses (1–2 g/day) are used in cardiovascular contexts and are more likely to need pharmacist or GP discussion.
What people use it for
Adults wanting to meet the EFSA / NHS adequate intake for long-chain omega-3 without eating fish
Algal EPA + DHA at ~250 mg combined per day matches the EFSA adequate intake. Suitable for vegans, vegetarians, and people who do not eat oily fish. [3]
Some evidenceStrongPregnant and breastfeeding women
DHA contributes to the normal brain and visual development of the foetus and breastfed infant — UK-authorised claim, conditional on a 200 mg DHA daily intake on top of the 250 mg adult EPA+DHA recommendation. Algal DHA is the established vegan-friendly source. [3,7]
Some evidenceStrongAdults wanting to support heart and blood-pressure markers
EPA and DHA contribute to normal heart function (250 mg/day combined), to maintenance of normal blood pressure (3 g/day combined), and to maintenance of normal blood triglyceride levels (2 g/day combined) — UK-authorised claims at the stated conditions of use. [3]
Some evidenceStrongAdults with dry eyes, attention concerns, or mood concerns
Trial evidence on these uses exists but does not currently translate to UK-authorised claims at supplement-label level. UK NHS pathways for these conditions apply.
Some evidenceLimitedPeople with bleeding disorders or on anticoagulants
Talk to your pharmacist or GP first. High-dose EPA + DHA (>3 g/day) has theoretical platelet effects and most clinical trials have not flagged clinically meaningful bleeding risk at standard doses, but disclosure matters.
Popular, not provenInsufficient
How it works
EPA and DHA are incorporated into cell membrane phospholipids, affecting membrane fluidity, signalling, and the synthesis of eicosanoids and specialised pro-resolving mediators (resolvins, protectins, maresins) that participate in the resolution of inflammation. DHA is a major structural lipid in retinal photoreceptor membranes and in the brain. EPA tends to dominate the cardiovascular-outcome literature; DHA dominates the neural and visual literature. The split is not absolute — the two interconvert to a limited degree in the body.
Common myths
Myth"Plant omega-3 from flax is the same as fish-oil omega-3"
RealityIt is not. Flaxseed, chia, hemp, walnut, and rapeseed oils provide alpha-linolenic acid (ALA), a short-chain omega-3. Fish and algal oils provide long-chain EPA and DHA. The body converts only a small fraction of ALA into EPA and very little into DHA. They are chemically related but functionally different supplements with different UK-authorised claims and conditions of use. [3]
Myth"Higher omega-3 dose is always better"
RealityAt standard 250 mg/day intake the adequate-intake claim applies and trials have not shown clinically meaningful additional benefit at modest dose escalation in healthy adults. Doses above 3 g/day combined sit in a space where benefits accrue in specific clinical populations (e.g. high triglycerides under a prescriber) and where bleeding-risk and gastrointestinal complaints become more likely. More is not better by default.
Myth"Algal omega-3 is contaminated with PCBs and mercury, like fish oil can be"
RealityAlgal oil is cultivated in closed fermenters from selected microalgal strains, which avoids the food-chain accumulation of environmental pollutants seen in long-lived predator fish. This is a meaningful contamination-profile advantage of algal sources over many fish-oil sources.
Myth"You only need omega-3 if you have a heart condition"
RealityEPA + DHA are essential dietary components contributing to normal function across multiple systems (heart, brain, vision). The UK adequate intake of 250 mg/day applies to healthy adults as a baseline, not just to people with diagnosed cardiovascular disease. [3]
Common online questions
Synthesised from the questions UK shoppers most often ask online about Vegan Omega-3 (Algal EPA + DHA). Each answer is editorial and links to its evidence in the Sources list below.
Is algal omega-3 as good as fish oil?
Yes, at equivalent EPA + DHA delivered. Algal oil is the upstream source of EPA and DHA — the fish accumulate it by eating algae. Algal oils are typically lower in heavy-metal contamination risk than fish oils (because they are cultivated in fermenters, not harvested from wild fish), and avoid the fishy taste and the sustainability concerns around forage-fish stocks.
Will my flaxseed oil give me the same omega-3 as fish oil?
No. Flaxseed (and chia, hemp, walnut) provides ALA, a different omega-3 fatty acid. The body converts a small fraction of ALA into EPA and very little into DHA — published conversion estimates in adults sit in single-digit percentages or lower. ALA is useful in its own right (it has its own UK-authorised cholesterol claim at 2 g/day) but it is not a substitute for an algal EPA + DHA supplement. [3]
Why do I need 250 mg / 2 g / 3 g — what determines the right dose?
The dose depends on which UK-authorised claim and which outcome. Adequate intake for general adult heart function is 250 mg/day combined EPA + DHA. Pregnancy adds 200 mg DHA on top of that. The triglyceride-maintenance claim is conditional on 2 g/day combined; the blood-pressure-maintenance claim on 3 g/day combined. Doses above 3 g/day move into a space where talking to a pharmacist makes sense (interaction with anticoagulants, clinical hypertriglyceridaemia management, etc.). [3]
Will algal oil thin my blood?
High-dose EPA + DHA has theoretical platelet effects. At standard consumer doses (≤1 g/day combined) clinical trials have not flagged meaningful bleeding risk. At higher doses, or when combined with prescribed anticoagulants and antiplatelets, talk to your prescribing pharmacist and disclose all supplements before any planned surgery.
Does the soft-gel need a fish-gelatin shell?
No. Algal oil soft-gels typically use a vegetarian capsule shell based on starch, carrageenan or modified cellulose rather than gelatin. If a product labelled "vegan" still uses fish or bovine gelatin, it is not vegan — read the capsule shell ingredient list, not just the marketing.
⚖️ The official position
What may lawfully be claimed about Vegan Omega-3 (Algal EPA + DHA) in Great Britain. This is a regulatory position, not an evidence grade.
A health claim is authorised in Great Britain.
“EPA and DHA contribute to the normal function of the heart”
“DHA contributes to maintenance of normal brain function”
“DHA contributes to the maintenance of normal vision”
“Maternal intake of DHA contributes to the normal brain development of the foetus and breastfed infants”
“Maternal intake of DHA contributes to the normal eye development of the foetus and breastfed infants”
“EPA and DHA contribute to the maintenance of normal blood pressure”
“EPA and DHA contribute to the maintenance of normal blood triglyceride levels”
This claim is authorised for use in Great Britain under the GB Nutrition and Health Claims regulation. A product may carry it when it provides at least 15% of the UK NRV per recommended daily portion.
Authorised UK health claims
Verbatim from the GB Nutrition and Health Claims Register (Reg 432/2012 as assimilated in GB). A product can carry these claims when it provides at least 15% of the UK NRV per recommended daily portion.
7 authorised claims — show / hide
- "EPA and DHA contribute to the normal function of the heart"
- "DHA contributes to maintenance of normal brain function"
- "DHA contributes to the maintenance of normal vision"
- "Maternal intake of DHA contributes to the normal brain development of the foetus and breastfed infants"
- "Maternal intake of DHA contributes to the normal eye development of the foetus and breastfed infants"
- "EPA and DHA contribute to the maintenance of normal blood pressure"
- "EPA and DHA contribute to the maintenance of normal blood triglyceride levels"
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Cardiovascular disease prevention (population level)
MixedEvidencemixedMeta-analyses of EPA + DHA supplementation conflict. The largest and most rigorous — the 2018 Cochrane review (Abdelhamid/Hooper, 79 RCTs, ~112,000 participants) — found little or no effect of EPA/DHA supplements on cardiovascular mortality or events, concluding earlier benefit signals came from higher-bias trials. Other meta-analyses (e.g. Khan 2021) report modest reductions in cardiovascular mortality and coronary events, alongside a small increase in atrial fibrillation and bleeding. Effect sizes depend on dose, duration, and baseline omega-3 status. Higher-dose prescription EPA (icosapent ethyl, REDUCE-IT) shows clearer benefit in specific high-triglyceride patients under prescribing supervision — a different setting from general consumer food supplementation. [8,9]
Cognitive decline / dementia prevention
LimitedEvidencelimitedTrials of EPA + DHA supplementation in healthy older adults have not shown consistent cognitive benefit. Some signals exist in sub-populations (low baseline omega-3 status, early decline), but UK NICE pathways for cognitive concerns do not list omega-3 as a treatment. [10]
Foetal and infant brain / visual development
StrongEvidencestrongDHA accumulates in the foetal brain and retina during the third trimester and the first two years of life. The UK-authorised claim is conditional on the mother consuming an additional 200 mg of DHA per day on top of the 250 mg/day adult adequate intake, during pregnancy and breastfeeding. [3,7]
Triglyceride lowering at supplemental doses
ModerateEvidencemoderateEPA + DHA at 2 g/day reduces fasting triglycerides — the basis for the UK-authorised maintenance claim. Larger doses (≥3 g/day) are typically used for established hypertriglyceridaemia and often sit in the prescribing space rather than self-supplemented territory. [3]
Safety
Algal EPA + DHA at consumer doses (≤1 g/day combined) is well-tolerated. Higher doses (>3 g/day combined) and combination with anticoagulants warrant a pharmacist conversation.
Talk to your pharmacist or GP first if you:
- You take an anticoagulant (warfarin, apixaban, rivaroxaban, dabigatran, edoxaban) or antiplatelet (clopidogrel, prasugrel, ticagrelor) — disclose at high doses (>1 g/day combined).
- You take prescribed omega-3 (icosapent ethyl, prescription fish oil) — duplicate-supplementation risk.
- You take blood-pressure medicines and are using high-dose EPA + DHA — discuss interaction.
- You have any planned surgery — disclose use, especially at high doses.
- You are pregnant or breastfeeding — talk through DHA dosing for the foetal development claim.
Common side effects: Mild GI complaints (fishy aftertaste, mild reflux, soft stools) at high doses. Algal oil is generally lower in fishy aftertaste than fish oil but not entirely absent.
Pregnancy and breastfeeding
Algal DHA is the established vegan-friendly source of long-chain omega-3 in pregnancy. The UK-authorised foetal-development claim is conditional on 200 mg DHA / day on top of the adult adequate intake of 250 mg/day combined EPA+DHA. Talk to your midwife or pharmacist to fit dosing into your antenatal vitamin regimen.
DHA passes into breast milk; the same 200 mg/day additional DHA recommendation applies during breastfeeding.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
More clinical detail (for clinicians and informed readers)
Contraindications
- Known hypersensitivity to algal oil constituents.
Drug interactions
- Theoretical platelet effects at high doses; combine with anticoagulants and antiplatelets only after pharmacist discussion.
- Concurrent prescription EPA / fish-oil products — duplicate dose.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Mild GI complaints — reflux, soft stools, occasional fishy aftertaste even with algal source.
Rare side effects
- Allergic reactions — rare; check ingredients if you have severe seafood or seaweed allergy (algal oil is not the same as seafood but cross-reactivity in extreme allergies has been reported anecdotally).
How to take it
- Typical supplemental range
- Adequate intake for general adults: ~250 mg/day combined EPA + DHA. Pregnancy / breastfeeding: + 200 mg/day DHA on top of the 250 mg/day. Triglyceride maintenance claim: 2 g/day combined. Blood-pressure maintenance claim: 3 g/day combined. Doses above 3 g/day are typically a prescribing-supervision setting.
- Timing
- No specific timing required for steady-state effect.
How to spot quality
Look for
- Algal source named (Schizochytrium sp. or Crypthecodinium cohnii are the standard commercial strains).
- EPA and DHA per serving stated separately, in mg — not just "omega-3 mg" totals (which can include ALA in misleading marketing).
- Capsule shell explicitly vegan/vegetarian (starch/carrageenan/modified cellulose, not gelatin).
- Antioxidant present in the soft-gel (rosemary extract, vitamin E) to prevent oxidation — algal oils are vulnerable to rancidity.
- Total oxidation (TOTOX) value or peroxide value declared in the spec — a freshness signal.
- GMP-certified manufacture; ideally Friend of the Sea / sustainability certification.
Red flags
- Label totals "omega-3" without separating EPA, DHA, ALA — this can hide ALA-dominant blends marketed as if they were EPA / DHA supplements.
- Marketing claims that algal oil is "10× more bioavailable" than fish oil — there is no evidence base for this.
- Soft-gel that turns out to use fish gelatin while marketed as vegan — read the capsule shell ingredient.
- Strong fishy smell or bitter aftertaste on opening capsules — likely oxidation; return.
- Claims of management or prevention of specific cardiovascular events, dementia, or depression — medicinal claims, not authorised.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Fish Oil (Long-Chain Omega-3 EPA / DHA, Marine Source)
Strong evidenceSister entry — algal DHA / EPA vs fish-oil DHA / EPA; same molecules, different supply chains.
Algal microalgae fermentation delivers DHA (and some EPA) without fish-source chain. Same UK Article 13.1 EPA / DHA authorised claims.
Evidence: Same molecules; equivalent UK regulatory tier. [11,12]
Doses studied: Use ONE — algal for vegan / pescatarian-avoiding; fish-oil for cost / availability.
Flaxseed (Linum usitatissimum) — whole seed, oil, and lignans
Moderate evidencePlant-omega cluster — algal DHA + flaxseed ALA covers both n-3 long-chain and short-chain.
Algal oil DHA / EPA bypasses ALA → EPA / DHA conversion limit; flaxseed provides upstream ALA + lignans. Mechanism complementary.
Evidence: Vegan / plant-based n-3 strategy; combination covers full chain. [13,14]
Doses studied: 500-1000 mg algal oil + 1-2 tbsp ground flaxseed daily.
Vitamin D3
Moderate evidenceVegan-friendly cluster — algal-source D3 (lichen) + algal-source omega-3.
Cholecalciferol from lichen + DHA / EPA from microalgae — both vegan-source bypassing fish liver oil traditional source.
Evidence: Vegan-cluster supplementation pattern. [3]
Doses studied: 500-1000 mg algal oil + 10-25 µg vitamin D3 (lichen-source) daily.